Clinical Trials Directory

Trials / Completed

CompletedNCT00255125

Role of Soy Supplementation in Prostate Cancer Development

Role of Soy Isoflavones in Prostate Cancer Prevention

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
86 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patient will be randomized it either receive placebo or a commercial soy supplement for 2-4 weeks prior to the planned surgery for treatment of their prostate cancer. Patient's blood and prostate tissue will be evaluated to determine the effects of the soy supplement on the prostate tissue.

Detailed description

This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patients will be randomized to either receive placebo or a commercial soy supplement for 2-4 weeks prior to the planned surgery for treatment of their prostate cancer. The specific objectives are: 1. To assess the effect of soy supplementation on endogenous hormone production levels and serum prostate specific antigens. 2. To assess the impact of soy supplementation on estrogen receptor expression(ER). 3. To determine the impact of soy isoflavones on cell cycle regulation and associated gene expression.

Conditions

Interventions

TypeNameDescription
DRUGSoy SupplementSoy protein supplement will be taken for 2-4 weeks until surgery to remove the prostate or start of radiation treatment. Patient will receive 4 capsules twice a day (8 capsules) daily to be taken with water or juice (except grapefruit juice).
DRUGPlaceboPlacebo will consist of a capsule without the soy protein added to be taken for 2-4 weeks until surgery to remove the prostate or start of radiation treatment. Patient will receive 4 capsules twice a day (8 capsules) daily to be taken with water or juice (except grapefruit juice).

Timeline

Start date
2005-09-01
Primary completion
2009-04-01
Completion
2009-10-01
First posted
2005-11-17
Last updated
2019-06-18
Results posted
2015-06-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00255125. Inclusion in this directory is not an endorsement.